BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32146833)

  • 1. Emerging therapies for the treatment of neonatal abstinence syndrome.
    Frazier LM; Bobby LE; Gawronski KM
    J Matern Fetal Neonatal Med; 2022 Mar; 35(5):987-995. PubMed ID: 32146833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid treatment for opioid withdrawal in newborn infants.
    Zankl A; Martin J; Davey JG; Osborn DA
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD002059. PubMed ID: 34231914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials.
    Ghazanfarpour M; Najafi MN; Roozbeh N; Mashhadi ME; Keramat-Roudi A; Mégarbane B; Tsatsakis A; Moghaddam MMM; Rezaee R
    Daru; 2019 Jun; 27(1):423-431. PubMed ID: 31093953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All.
    McPherson C
    Neonatal Netw; 2016; 35(5):314-20. PubMed ID: 27636696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.
    Davis JM; Shenberger J; Terrin N; Breeze JL; Hudak M; Wachman EM; Marro P; Oliveira EL; Harvey-Wilkes K; Czynski A; Engelhardt B; D'Apolito K; Bogen D; Lester B
    JAMA Pediatr; 2018 Aug; 172(8):741-748. PubMed ID: 29913015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal abstinence syndrome after methadone or buprenorphine exposure.
    Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Fischer G
    N Engl J Med; 2010 Dec; 363(24):2320-31. PubMed ID: 21142534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.
    Noormohammadi A; Forinash A; Yancey A; Crannage E; Campbell K; Shyken J
    Ann Pharmacother; 2016 Aug; 50(8):666-72. PubMed ID: 27199497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonidine versus phenobarbital as adjunctive therapy for neonatal abstinence syndrome.
    Brusseau C; Burnette T; Heidel RE
    J Perinatol; 2020 Jul; 40(7):1050-1055. PubMed ID: 32424335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.
    Klaman SL; Isaacs K; Leopold A; Perpich J; Hayashi S; Vender J; Campopiano M; Jones HE
    J Addict Med; 2017; 11(3):178-190. PubMed ID: 28406856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of neonatal abstinence syndrome in neonates born to opioid maintained women.
    Ebner N; Rohrmeister K; Winklbaur B; Baewert A; Jagsch R; Peternell A; Thau K; Fischer G
    Drug Alcohol Depend; 2007 Mar; 87(2-3):131-8. PubMed ID: 17000060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine compared with methadone in opioid-dependent pregnant women: How does it affect neonatal abstinence syndrome?
    Bivin B; Waring A; Alves P
    J Am Assoc Nurse Pract; 2019 Dec; 33(2):119-125. PubMed ID: 31809398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome.
    Hall ES; Isemann BT; Wexelblatt SL; Meinzen-Derr J; Wiles JR; Harvey S; Akinbi HT
    J Pediatr; 2016 Mar; 170():39-44.e1. PubMed ID: 26703873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
    Gaalema DE; Scott TL; Heil SH; Coyle MG; Kaltenbach K; Badger GJ; Arria AM; Stine SM; Martin PR; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome.
    Young ME; Hager SJ; Spurlock D
    Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S162-7. PubMed ID: 26582303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.
    Brogly SB; Saia KA; Walley AY; Du HM; Sebastiani P
    Am J Epidemiol; 2014 Oct; 180(7):673-86. PubMed ID: 25150272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine and Methadone for Neonatal Abstinence Syndrome: A Systematic Review.
    Slowiczek L; Hein DJ; Risoldi Cochrane Z; Gregory PJ
    Neonatal Netw; 2018 Nov; 37(6):365-371. PubMed ID: 30567886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for the Treatment of Neonatal Abstinence Syndrome.
    Cook CE; Fantasia HC
    Nurs Womens Health; 2019 Aug; 23(4):357-365. PubMed ID: 31251931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of opioid replacement agents for neonatal opioid withdrawal syndrome: a systematic review and meta-analysis.
    Lee JJ; Chen J; Eisler L; Li G; Davis JM; Sun LS
    J Perinatol; 2019 Nov; 39(11):1535-1545. PubMed ID: 31316147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome.
    Hall ES; Wexelblatt SL; Crowley M; Grow JL; Jasin LR; Klebanoff MA; McClead RE; Meinzen-Derr J; Mohan VK; Stein H; Walsh MC;
    Pediatrics; 2014 Aug; 134(2):e527-34. PubMed ID: 25070317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.